Almkvist O

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (16)

Title : CSF Cholinergic Index, a New Biomeasure of Treatment Effect in Patients With Alzheimer's Disease - Karami_2019_Front.Mol.Neurosci_12_239
Author(s) : Karami A , Eriksdotter M , Kadir A , Almkvist O , Nordberg A , Darreh-Shori T
Ref : Front Mol Neurosci , 12 :239 , 2019
Abstract : Karami_2019_Front.Mol.Neurosci_12_239
ESTHER : Karami_2019_Front.Mol.Neurosci_12_239
PubMedSearch : Karami_2019_Front.Mol.Neurosci_12_239
PubMedID: 31680850

Title : Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device - Eyjolfsdottir_2016_Alzheimers.Res.Ther_8_30
Author(s) : Eyjolfsdottir H , Eriksdotter M , Linderoth B , Lind G , Juliusson B , Kusk P , Almkvist O , Andreasen N , Blennow K , Ferreira D , Westman E , Nennesmo I , Karami A , Darreh-Shori T , Kadir A , Nordberg A , Sundstrom E , Wahlund LO , Wall A , Wiberg M , Winblad B , Seiger A , Wahlberg L , Almqvist P
Ref : Alzheimers Res Ther , 8 :30 , 2016
Abstract : Eyjolfsdottir_2016_Alzheimers.Res.Ther_8_30
ESTHER : Eyjolfsdottir_2016_Alzheimers.Res.Ther_8_30
PubMedSearch : Eyjolfsdottir_2016_Alzheimers.Res.Ther_8_30
PubMedID: 27389402

Title : Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease - Darreh-Shori_2013_Neurobiol.Aging_34_2465
Author(s) : Darreh-Shori T , Vijayaraghavan S , Aeinehband S , Piehl F , Lindblom RP , Nilsson B , Ekdahl KN , Langstrom B , Almkvist O , Nordberg A
Ref : Neurobiology of Aging , 34 :2465 , 2013
Abstract : Darreh-Shori_2013_Neurobiol.Aging_34_2465
ESTHER : Darreh-Shori_2013_Neurobiol.Aging_34_2465
PubMedSearch : Darreh-Shori_2013_Neurobiol.Aging_34_2465
PubMedID: 23759148

Title : Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo - Darreh-Shori_2011_Neurobiol.Aging_32_2320 e15
Author(s) : Darreh-Shori T , Forsberg A , Modiri N , Andreasen N , Blennow K , Kamil C , Ahmed H , Almkvist O , Langstrom B , Nordberg A
Ref : Neurobiology of Aging , 32 :2320 e15 , 2011
Abstract : Darreh-Shori_2011_Neurobiol.Aging_32_2320 e15
ESTHER : Darreh-Shori_2011_Neurobiol.Aging_32_2320 e15
PubMedSearch : Darreh-Shori_2011_Neurobiol.Aging_32_2320 e15
PubMedID: 20538374

Title : Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease - Kadir_2011_Brain_134_301
Author(s) : Kadir A , Marutle A , Gonzalez D , Scholl M , Almkvist O , Mousavi M , Mustafiz T , Darreh-Shori T , Nennesmo I , Nordberg A
Ref : Brain , 134 :301 , 2011
Abstract : Kadir_2011_Brain_134_301
ESTHER : Kadir_2011_Brain_134_301
PubMedSearch : Kadir_2011_Brain_134_301
PubMedID: 21149866

Title : Inhibition of acetylcholinesterase in CSF versus brain assessed by 11C-PMP PET in AD patients treated with galantamine - Darreh-Shori_2008_Neurobiol.Aging_29_168
Author(s) : Darreh-Shori T , Kadir A , Almkvist O , Grut M , Wall A , Blomquist G , Eriksson B , Langstrom B , Nordberg A
Ref : Neurobiology of Aging , 29 :168 , 2008
Abstract : Darreh-Shori_2008_Neurobiol.Aging_29_168
ESTHER : Darreh-Shori_2008_Neurobiol.Aging_29_168
PubMedSearch : Darreh-Shori_2008_Neurobiol.Aging_29_168
PubMedID: 17196712

Title : PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD - Kadir_2008_Neurobiol.Aging_29_1204
Author(s) : Kadir A , Darreh-Shori T , Almkvist O , Wall A , Grut M , Strandberg B , Ringheim A , Eriksson B , Blomquist G , Langstrom B , Nordberg A
Ref : Neurobiology of Aging , 29 :1204 , 2008
Abstract : Kadir_2008_Neurobiol.Aging_29_1204
ESTHER : Kadir_2008_Neurobiol.Aging_29_1204
PubMedSearch : Kadir_2008_Neurobiol.Aging_29_1204
PubMedID: 17379359

Title : Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET - Kadir_2007_Psychopharmacology.(Berl)_191_1005
Author(s) : Kadir A , Darreh-Shori T , Almkvist O , Wall A , Langstrom B , Nordberg A
Ref : Psychopharmacology (Berl) , 191 :1005 , 2007
Abstract : Kadir_2007_Psychopharmacology.(Berl)_191_1005
ESTHER : Kadir_2007_Psychopharmacology.(Berl)_191_1005
PubMedSearch : Kadir_2007_Psychopharmacology.(Berl)_191_1005
PubMedID: 17310387

Title : Two-year follow-up of amyloid deposition in patients with Alzheimer's disease - Engler_2006_Brain_129_2856
Author(s) : Engler H , Forsberg A , Almkvist O , Blomquist G , Larsson E , Savitcheva I , Wall A , Ringheim A , Langstrom B , Nordberg A
Ref : Brain , 129 :2856 , 2006
Abstract : Engler_2006_Brain_129_2856
ESTHER : Engler_2006_Brain_129_2856
PubMedSearch : Engler_2006_Brain_129_2856
PubMedID: 16854944

Title : Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer's disease - Stefanova_2006_J.Neural.Transm.(Vienna)_113_205
Author(s) : Stefanova E , Wall A , Almkvist O , Nilsson A , Forsberg A , Langstrom B , Nordberg A
Ref : J Neural Transm (Vienna) , 113 :205 , 2006
Abstract : Stefanova_2006_J.Neural.Transm.(Vienna)_113_205
ESTHER : Stefanova_2006_J.Neural.Transm.(Vienna)_113_205
PubMedSearch : Stefanova_2006_J.Neural.Transm.(Vienna)_113_205
PubMedID: 16049637

Title : Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE epsilon4 allele, in relation to cognitive function and cerebral glucose metabolism - Darreh-Shori_2006_Neurobiol.Dis_24_326
Author(s) : Darreh-Shori T , Brimijoin S , Kadir A , Almkvist O , Nordberg A
Ref : Neurobiol Dis , 24 :326 , 2006
Abstract : Darreh-Shori_2006_Neurobiol.Dis_24_326
ESTHER : Darreh-Shori_2006_Neurobiol.Dis_24_326
PubMedSearch : Darreh-Shori_2006_Neurobiol.Dis_24_326
PubMedID: 16973370

Title : Preserved cognitive function after 12 months of treatment with rivastigmine in mild Alzheimer's disease in comparison with untreated AD and MCI patients - Almkvist_2004_Eur.J.Neurol_11_253
Author(s) : Almkvist O , Darreh-Shori T , Stefanova E , Spiegel R , Nordberg A
Ref : Eur Journal of Neurology , 11 :253 , 2004
Abstract : Almkvist_2004_Eur.J.Neurol_11_253
ESTHER : Almkvist_2004_Eur.J.Neurol_11_253
PubMedSearch : Almkvist_2004_Eur.J.Neurol_11_253
PubMedID: 15061827

Title : Cerebral glucose metabolism, cerebrospinal fluid-beta-amyloid(1-42) (CSF-Abeta42), tau and apolipoprotein E genotype in long-term rivastigmine and tacrine treated Alzheimer disease (AD) patients - Stefanova_2003_Neurosci.Lett_338_159
Author(s) : Stefanova E , Blennow K , Almkvist O , Hellstrom-Lindahl E , Nordberg A
Ref : Neuroscience Letters , 338 :159 , 2003
Abstract : Stefanova_2003_Neurosci.Lett_338_159
ESTHER : Stefanova_2003_Neurosci.Lett_338_159
PubMedSearch : Stefanova_2003_Neurosci.Lett_338_159
PubMedID: 12566177

Title : Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months - Darreh-Shori_2002_Neurology_59_563
Author(s) : Darreh-Shori T , Almkvist O , Guan ZZ , Garlind A , Strandberg B , Svensson AL , Soreq H , Hellstrom-Lindahl E , Nordberg A
Ref : Neurology , 59 :563 , 2002
Abstract : Darreh-Shori_2002_Neurology_59_563
ESTHER : Darreh-Shori_2002_Neurology_59_563
PubMedSearch : Darreh-Shori_2002_Neurology_59_563
PubMedID: 12196650

Title : Responder characteristics to a single oral dose of cholinesterase inhibitor: a double-blind placebo-controlled study with tacrine in Alzheimer patients - Almkvist_2001_Dement.Geriatr.Cogn.Disord_12_22
Author(s) : Almkvist O , Jelic V , Amberla K , Hellstrom-Lindahl E , Meurling L , Nordberg A
Ref : Dementia & Geriatric Cognitive Disorders , 12 :22 , 2001
Abstract : Almkvist_2001_Dement.Geriatr.Cogn.Disord_12_22
ESTHER : Almkvist_2001_Dement.Geriatr.Cogn.Disord_12_22
PubMedSearch : Almkvist_2001_Dement.Geriatr.Cogn.Disord_12_22
PubMedID: 11125238

Title : Longitudinal changes in quantitative EEG during long-term tacrine treatment of patients with Alzheimer's disease - Jelic_1998_Neurosci.Lett_254_85
Author(s) : Jelic V , Dierks T , Amberla K , Almkvist O , Winblad B , Nordberg A
Ref : Neuroscience Letters , 254 :85 , 1998
Abstract : Jelic_1998_Neurosci.Lett_254_85
ESTHER : Jelic_1998_Neurosci.Lett_254_85
PubMedSearch : Jelic_1998_Neurosci.Lett_254_85
PubMedID: 9779926